Summary

[dangerport01 Users]

dangerport01 Users

• 

Offline

Show Posts
Show Stats

Posts:

0 (N/A per day)

Age:

N/A

Date Registered:

Yesterday at 22:14:15

Local Time:

2025-08-15, 05:00:27

Last Active:

Today at 00:38:03

Signature:

Vismodegib has shown clinical efficacy in the management of locally advanced basal cell carcinomas (laBCC). However, non-response to vismodegib is obs